|
Characteristics
|
Number of patients
|
Percentage
|
|---|
|
Age
| | |
|
≤ 60
|
12
|
38.7
|
|
> 60
|
19
|
61.3
|
|
Gender
| | |
|
Male
|
23
|
74.2
|
|
Female
|
8
|
25.8
|
|
ECOG PS
| | |
|
0-1
|
27
|
87.1
|
|
2-4
|
4
|
12.9
|
|
B symptom
| | |
|
Absent
|
14
|
48.3
|
|
Present
|
15
|
51.7
|
|
Bulky disease
| | |
|
Absent
|
21
|
67.7
|
|
Present
|
10
|
32.3
|
|
LDH
| | |
|
Normal
|
4
|
12.9
|
|
Elevated
|
27
|
87.1
|
|
Primary site of adrenal gland
| | |
|
Unilateral
|
12
|
38.7
|
|
Bilateral
|
19
|
61.3
|
|
Adrenal insufficiency
| | |
|
Absent
|
10
|
62.5
|
|
Present
|
6
|
37.5
|
|
Ann Arbor stage
| | |
|
IE, IIE
|
5
|
16.1
|
|
IIIE, IV
|
26
|
83.9
|
|
Number of extranodal sites
| | |
|
0-1
|
7
|
22.6
|
|
2 or more
|
24
|
77.4
|
|
Ki-67 LI
| | |
|
> 80%
|
11
|
57.9
|
|
≤ 80%
|
8
|
42.1
|
|
IPI
| | |
|
Low/Low-intermediate
|
8
|
25.8
|
|
High-intermediate/High
|
23
|
74.2
|
- ECOG PS, Eastern Cooperative Oncology Group performance status; LDH, lactate dehydrogenase; Ki-67 LI, Ki-67 labeling Index; IPI, International Prognostic Index.
